A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

NCT04327011 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

65

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Glioblastoma Multiforme
Astrocytoma
Gliomas, Malignant

Interventions

BIOLOGICAL: Toca 511 vector
DRUG: Toca FC • Flucytosine • 5-FC • 5-Fluorocytosine

Sponsor

Tocagen Inc.